Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k) submission with method comparison, usability, ...
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...
Novo Nordisk will present the ORION study at the upcoming Obesity Medicine Association’s annual conference in San Diego ...
In the first head-to-head comparison of two blockbuster drugs used in real-world conditions, people who took Mounjaro lost significantly more weight than their counterparts who took Ozempic — and the ...
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
BOSTON--(BUSINESS WIRE)--Since the school closings in 2020, educators have been looking for ways to help students accelerate learning to recover lost ground. RAND Education and Labor, a division of ...
June 18 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. When endocrinologist Mary Elizabeth Patti looks ...
ChatGPT pulls 6x more pages than it cites, concentrating visibility among ~30 domains and favoring topic-wide coverage, study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results